Nadine Dragin

2.0k total citations
32 papers, 1.6k citations indexed

About

Nadine Dragin is a scholar working on Neurology, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Nadine Dragin has authored 32 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Neurology, 8 papers in Molecular Biology and 8 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Nadine Dragin's work include Myasthenia Gravis and Thymoma (11 papers), Carcinogens and Genotoxicity Assessment (7 papers) and Pharmacogenetics and Drug Metabolism (7 papers). Nadine Dragin is often cited by papers focused on Myasthenia Gravis and Thymoma (11 papers), Carcinogens and Genotoxicity Assessment (7 papers) and Pharmacogenetics and Drug Metabolism (7 papers). Nadine Dragin collaborates with scholars based in France, United States and Sweden. Nadine Dragin's co-authors include Daniel W. Nebert, Sonia Berrih‐Aknin, Rozen Le Panse, Shigeyuki Uno, Timothy P. Dalton, Marian L. Miller, Zhanquan Shi, José Adolfo Villegas, Frank J. Gonzalez and Howard G. Shertzer and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Reviews Genetics.

In The Last Decade

Nadine Dragin

30 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nadine Dragin France	22	394	336	324	280	273	32	1.6k
Paolo Moi Italy	23	1.9k 4.8×	37 0.1×	133 0.4×	58 0.2×	164 0.6×	60	2.9k
Soona Shin United States	20	1.6k 4.0×	30 0.1×	107 0.3×	95 0.3×	177 0.6×	27	2.3k
Palanisamy Nallasamy United States	21	670 1.7×	46 0.1×	26 0.1×	60 0.2×	282 1.0×	38	1.5k
Zhangyin Ming China	19	556 1.4×	34 0.1×	28 0.1×	65 0.2×	236 0.9×	39	1.3k
B. Kevin Park United Kingdom	9	1.0k 2.6×	31 0.1×	44 0.1×	196 0.7×	164 0.6×	11	1.6k
Yukari Zenke Japan	8	2.0k 5.2×	39 0.1×	101 0.3×	55 0.2×	317 1.2×	17	2.5k
Mohammad Zahid Ashraf India	22	546 1.4×	55 0.2×	25 0.1×	27 0.1×	267 1.0×	50	1.4k
Kozue Takeda Japan	21	714 1.8×	19 0.1×	71 0.2×	82 0.3×	452 1.7×	34	1.6k
Kimie Nakagawa Japan	22	424 1.1×	137 0.4×	36 0.1×	55 0.2×	72 0.3×	77	2.1k

Countries citing papers authored by Nadine Dragin

Since Specialization

Citations

This map shows the geographic impact of Nadine Dragin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nadine Dragin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nadine Dragin more than expected).

Fields of papers citing papers by Nadine Dragin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nadine Dragin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nadine Dragin. The network helps show where Nadine Dragin may publish in the future.

Co-authorship network of co-authors of Nadine Dragin

This figure shows the co-authorship network connecting the top 25 collaborators of Nadine Dragin. A scholar is included among the top collaborators of Nadine Dragin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nadine Dragin. Nadine Dragin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pinzón, Natalia, Nadine Dragin, Aurélien Corneau, et al.. (2025). Mesenchymal stromal cells conditioned by peripheral blood mononuclear cells exert enhanced immunomodulation capacities and alleviate a model of Myasthenia Gravis. Stem Cell Research & Therapy. 16(1). 437–437. 1 indexed citations

Vilquin, Jean‐Thomas, et al.. (2025). Development of a refined experimental mouse model of myasthenia gravis with anti-acetylcholine receptor antibodies. Frontiers in Immunology. 16. 1521382–1521382.

Villegas, José Adolfo, Karen Matta, Frédérique Truffault, et al.. (2023). Blocking interleukin-23 ameliorates neuromuscular and thymic defects in myasthenia gravis. Journal of Neuroinflammation. 20(1). 9–9. 5 indexed citations

Villegas, José Adolfo, et al.. (2020). Estrogen, estrogen-like molecules and autoimmune diseases. Autoimmunity Reviews. 19(3). 102468–102468. 61 indexed citations

Villegas, José Adolfo, Jacky Bismuth, Frédérique Truffault, et al.. (2018). Il-23/Th17 cell pathway: A promising target to alleviate thymic inflammation maintenance in myasthenia gravis. Journal of Autoimmunity. 98. 59–73. 42 indexed citations

Sudres, Muriel, Marie Maurer, Jacky Bismuth, et al.. (2017). Preconditioned mesenchymal stem cells treat myasthenia gravis in a humanized preclinical model. JCI Insight. 2(7). e89665–e89665. 21 indexed citations

Dragin, Nadine, Rozen Le Panse, & Sonia Berrih‐Aknin. (2017). Prédisposition aux pathologies auto-immmunes. médecine/sciences. 33(2). 169–175. 10 indexed citations

Dragin, Nadine, Patrice Nancy, José Adolfo Villegas, et al.. (2017). Balance between Estrogens and Proinflammatory Cytokines Regulates Chemokine Production Involved in Thymic Germinal Center Formation. Scientific Reports. 7(1). 7970–7970. 46 indexed citations

Nebert, Daniel W., Zhanquan Shi, Marina Gálvez‐Peralta, Shigeyuki Uno, & Nadine Dragin. (2013). Oral Benzo[a]pyrene: Understanding Pharmacokinetics, Detoxication, and Consequences—Cyp1 Knockout Mouse Lines as a Paradigm. Molecular Pharmacology. 84(3). 304–313. 110 indexed citations

10.

Cufi, Perrine, Nadine Dragin, Julia Miriam Weiss, et al.. (2012). Implication of double‐stranded RNA signaling in the etiology of autoimmune myasthenia gravis. Annals of Neurology. 73(2). 281–293. 71 indexed citations

11.

Shi, Zhanquan, Nadine Dragin, Marian L. Miller, et al.. (2010). Oral benzo[a]pyrene‐induced cancer: Two distinct types in different target organs depend on the mouseCyp1genotype. International Journal of Cancer. 127(10). 2334–2350. 40 indexed citations

12.

Uno, Shigeyuki, Nadine Dragin, Marian L. Miller, et al.. (2007). Basal and inducible CYP1 mRNA quantitation and protein localization throughout the mouse gastrointestinal tract. Free Radical Biology and Medicine. 44(4). 570–583. 63 indexed citations

13.

Dragin, Nadine, Shigeyuki Uno, Bin Wang, Timothy P. Dalton, & Daniel W. Nebert. (2007). Generation of ‘humanized’ hCYP1A1_1A2_Cyp1a1/1a2(−/−) mouse line. Biochemical and Biophysical Research Communications. 359(3). 635–642. 55 indexed citations

14.

Genter, Mary Beth, Jennifer Marlowe, J. Kevin Kerzee, et al.. (2006). Naphthalene toxicity in mice and aryl hydrocarbon receptor-mediated CYPs. Biochemical and Biophysical Research Communications. 348(1). 120–123. 27 indexed citations

15.

Wang, Bin, Scott N. Schneider, Nadine Dragin, et al.. (2006). Enhanced cadmium-induced testicular necrosis and renal proximal tubule damage caused by gene-dose increase in aSlc39a8-transgenic mouse line. American Journal of Physiology-Cell Physiology. 292(4). C1523–C1535. 90 indexed citations

16.

Dragin, Nadine, Timothy P. Dalton, Marian L. Miller, Howard G. Shertzer, & Daniel W. Nebert. (2006). For Dioxin-induced Birth Defects, Mouse or Human CYP1A2 in Maternal Liver Protects whereas Mouse CYP1A1 and CYP1B1 Are Inconsequential. Journal of Biological Chemistry. 281(27). 18591–18600. 38 indexed citations

17.

Jiang, Zhengwen, Nadine Dragin, Lucia F. Jorge-Nebert, et al.. (2006). Search for an association between the human CYP1A2 genotype and CYP1A2 metabolic phenotype. Pharmacogenetics and Genomics. 16(5). 359–367. 73 indexed citations

18.

Wesselkamper, Scott C., Lisa N. Henning, Michael T. Borchers, et al.. (2005). Gene Expression Changes during the Development of Acute Lung Injury Role of Transforming Growth Factor β. American Journal of Respiratory and Critical Care Medicine. 172(11). 1399–1411. 53 indexed citations

19.

Curran, Christine, et al.. (2005). Theophylline pharmacokinetics: comparison of Cyp1a1(−/−) and Cyp1a2(−/−) knockout mice, humanized hCYP1A1_1A2 knock-in mice lacking either the mouse Cyp1a1 or Cyp1a2 gene, and Cyp1(+/+) wild-type mice. Pharmacogenetics and Genomics. 15(7). 503–511. 29 indexed citations

20.

Uno, Shigeyuki, Timothy P. Dalton, Nadine Dragin, et al.. (2005). Oral Benzo[a]pyrene in Cyp1 Knockout Mouse Lines: CYP1A1 Important in Detoxication, CYP1B1 Metabolism Required for Immune Damage Independent of Total-Body Burden and Clearance Rate. Molecular Pharmacology. 69(4). 1103–1114. 174 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact